Ningbo Menovo Pharmaceutical Co.,Ltd.’s Net Profit Rose 132.6% in 2022

Ningbo Menovo Pharmaceutical Co.,Ltd. (宁波美诺华药业股份有限公司) (603538.SH) reported a net profit of 367.6 million yuan in 2022, up 132.6% year-on-year.

Meanwhile, the company posted 1.5 billion yuan in revenue, up 15.8% year-on-year.

At the end of the reporting period, it had 4.4 billion yuan in total assets and 2.2 billion yuan in total liabilities, with a liability-to-asset ratio of 50.8%.